AHCTA members commit themselves to the harmonisation of their respective standards with the objective of creating a single set of quality, safety and professional requirements for cellular therapy including haematopoietic stem cell (HSC) transplantation. These standards will comprehensively cover all aspects of the process from assessment of donor eligibility to transplantation and clinical outcome. This commitment will be supported by collaboration on the drafting of complementary standards and guidelines, promotion of the concept of a global set of standards among the cellular therapy professional community and regulatory authorities and regular communication on all relevant issues affecting cellular therapy guidelines.

AHCTA regards regulatory authorities as partners in the application of these global standards, essential to their successful adoption and will endeavour to inform and support these authorities in the area of cellular therapy regulation.